Back to Search
RABIA MOHAMMAD M.D.
M.D.
Internal Medicine Physician
NPI: 1851753040IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist Physician
Hospitalist
Code: 208M00000X
01083288A(IN)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
01083288A(IN)
Education
OTHER
Class of 2011
Research & Publications (20)
Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.
PMID 18289121·Recent Pat Anticancer Drug Discov·2008
6-review
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
PMID 17404107·Clin Cancer Res·2007
7-preclinical
Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.
PMID 15657349·Mol Cancer Ther·2005
7-preclinical
Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line.
PMID 16258364·Pancreas·2005
8-other
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.
PMID 14707277·Mol Cancer Ther·2003
7-preclinical
Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.
PMID 12442811·J Drug Target·2002
5-case
Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
PMID 11948143·Clin Cancer Res·2002
7-preclinical
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.
PMID 11593055·Anticancer Drugs·2001
7-preclinical
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
PMID 11156256·Clin Cancer Res·2000
7-preclinical
Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
PMID 19509168·Clin Cancer Res·2009
4-observational
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status.
PMID 19220884·J Hematol Oncol·2009
7-preclinical
A combination method to study microbial communities and activities in zinc contaminated soil.
PMID 19443111·J Hazard Mater·2009
8-other
Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.
PMID 19318602·Ann Pharmacother·2009
4-observational
Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage.
PMID 19249944·Pharmacotherapy·2009
8-other
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.
PMID 18767026·J Cell Physiol·2009
6-review
Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners.
PMID 19323626·Pharmacotherapy·2009
8-other
Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells.
PMID 19505895·Mutagenesis·2009
8-other
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway.
PMID 19318573·Cancer Res·2009
7-preclinical
Efficacy of selected natural products as therapeutic agents against cancer.
PMID 18302335·J Nat Prod·2008
6-review
Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis.
PMID 18790769·Mol Cancer Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2601 Ocean Pkwy
Brooklyn, NY 11235 - Phone
- (917) 615-4407
Quick Facts
- NPI
- 1851753040
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile